Published in

BMJ Publishing Group, BMJ, jun04 2(348), p. g3510-g3510

DOI: 10.1136/bmj.g3510

Links

Tools

Export citation

Search in Google Scholar

Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications

Journal article published in 2014 by Emma Maund, Britta Tendal, Asbj Hróbjartsson, Karsten Juhl Jørgensen, Andreas Lundh, Jeppe Schroll ORCID, Peter C. Gøtzsche
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Objective To determine, using research on duloxetine for major depressive disorder as an example, if there are inconsistencies between protocols, clinical study reports, and main publicly available sources (journal articles and trial registries), and within clinical study reports themselves, with respect to benefits and major harms.